Company Filing History:
Years Active: 2018
Title: Innovations of Mei-Kwan Yau in Protease Activated Receptors
Introduction
Mei-Kwan Yau is a notable inventor based in Brisbane, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for therapeutic applications.
Latest Patents
One of his key patents is titled "Modulators of Protease Activated Receptors." This invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds, and methods for using these compounds as tools for biological studies. The compounds are designed to be used as agents or drugs for therapies targeting metabolic syndrome, obesity, type II diabetes, fibrosis, and cardiovascular diseases, whether used alone or in combination with other treatment modalities. He holds 1 patent in this area.
Career Highlights
Mei-Kwan Yau is affiliated with The University of Queensland, where he continues to engage in innovative research. His work has been instrumental in advancing our understanding of protease activated receptors and their implications in various health conditions.
Collaborations
He has collaborated with esteemed colleagues such as David P Fairlie and Ligong Liu, contributing to a rich environment of research and innovation.
Conclusion
Mei-Kwan Yau's work exemplifies the intersection of scientific research and practical application in medicine. His contributions to the field of protease activated receptors are paving the way for new therapeutic strategies.